Operationalizing the GRADE-equity criterion to inform guideline recommendations: application to a medical cannabis guideline

J Clin Epidemiol. 2024 Jan:165:111185. doi: 10.1016/j.jclinepi.2023.10.001. Epub 2023 Nov 11.

Abstract

Objectives: Incorporating health equity considerations into guideline development often requires information beyond that gathered through traditional evidence synthesis methodology. This article outlines an operationalization plan for the Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-equity criterion to gather and assess evidence from primary studies within systematic reviews, enhancing guideline recommendations to promote equity. We demonstrate its use in a clinical guideline on medical cannabis for chronic pain.

Study design and setting: We reviewed GRADE guidance and resources recommended by team members regarding the use of evidence for equity considerations, drafted an operationalization plan, and iteratively refined it through team discussion and feedback and piloted it on a medicinal cannabis guideline.

Results: We propose a seven-step approach: 1) identify disadvantaged populations, 2) examine available data for specific populations, 3) evaluate population baseline risk for primary outcomes, 4) assess representation of these populations in primary studies, 5) appraise analyses, 6) note barriers to implementation of effective interventions for these populations, and 7) suggest supportive strategies to facilitate implementation of effective interventions.

Conclusion: Our approach assists guideline developers in recognizing equity considerations, particularly in resource-constrained settings. Its application across various guideline topics can verify its feasibility and necessary adjustments.

Keywords: Considerations; Equity; GRADE; Guidelines; Implementation; Representation; Reviews.

Publication types

  • Review

MeSH terms

  • Chronic Pain* / drug therapy
  • Health Equity*
  • Humans
  • Medical Marijuana* / therapeutic use
  • Research Design
  • Vulnerable Populations

Substances

  • Medical Marijuana